Cargando…
Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic manifestations (RVCL-S) is a small vessel disease caused by TREX1 mutations. RVCL-S is characterized by retinal vasculopathy and brain white matter lesions with and without contrast enhancement. We aimed to investigate cerebrovascul...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983338/ https://www.ncbi.nlm.nih.gov/pubmed/33736510 http://dx.doi.org/10.1177/0271678X20929430 |
_version_ | 1783667885491617792 |
---|---|
author | Hoogeveen, Evelien S Pelzer, Nadine Ghariq, Eidrees van Osch, Matthias JP Dahan, Albert Terwindt, Gisela M Kruit, Mark C |
author_facet | Hoogeveen, Evelien S Pelzer, Nadine Ghariq, Eidrees van Osch, Matthias JP Dahan, Albert Terwindt, Gisela M Kruit, Mark C |
author_sort | Hoogeveen, Evelien S |
collection | PubMed |
description | Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic manifestations (RVCL-S) is a small vessel disease caused by TREX1 mutations. RVCL-S is characterized by retinal vasculopathy and brain white matter lesions with and without contrast enhancement. We aimed to investigate cerebrovascular reactivity (CVR) in RVCL-S. In this cross-sectional observational study, 21 RVCL-S patients, 23 mutation-negative family members, and 31 healthy unrelated controls were included. CVR to a hypercapnic challenge was measured using dual-echo arterial spin labeling magnetic resonance imaging. Stratified analyses based on age were performed. We found that CVR was decreased in gray and white matter of RVCL-S patients compared with family members and healthy controls (ANCOVA; P < 0.05 for all comparisons). This was most noticeable in RVCL-S patients aged ≥40 years (ANCOVA, P < 0.05 for all comparisons). In RVCL-S patients aged < 40 years, only CVR in white matter was lower when compared to healthy controls (P < 0.05). Gray matter CVR was associated with white matter lesion volume in RVCL-S patients (r = –0.527, P = 0.01). In conclusion, impaired cerebrovascular reactivity may play an important role in the pathophysiology of RVCL-S and may be an useful early biomarker of cerebrovascular disease severity. |
format | Online Article Text |
id | pubmed-7983338 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-79833382021-03-31 Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations Hoogeveen, Evelien S Pelzer, Nadine Ghariq, Eidrees van Osch, Matthias JP Dahan, Albert Terwindt, Gisela M Kruit, Mark C J Cereb Blood Flow Metab Original Articles Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic manifestations (RVCL-S) is a small vessel disease caused by TREX1 mutations. RVCL-S is characterized by retinal vasculopathy and brain white matter lesions with and without contrast enhancement. We aimed to investigate cerebrovascular reactivity (CVR) in RVCL-S. In this cross-sectional observational study, 21 RVCL-S patients, 23 mutation-negative family members, and 31 healthy unrelated controls were included. CVR to a hypercapnic challenge was measured using dual-echo arterial spin labeling magnetic resonance imaging. Stratified analyses based on age were performed. We found that CVR was decreased in gray and white matter of RVCL-S patients compared with family members and healthy controls (ANCOVA; P < 0.05 for all comparisons). This was most noticeable in RVCL-S patients aged ≥40 years (ANCOVA, P < 0.05 for all comparisons). In RVCL-S patients aged < 40 years, only CVR in white matter was lower when compared to healthy controls (P < 0.05). Gray matter CVR was associated with white matter lesion volume in RVCL-S patients (r = –0.527, P = 0.01). In conclusion, impaired cerebrovascular reactivity may play an important role in the pathophysiology of RVCL-S and may be an useful early biomarker of cerebrovascular disease severity. SAGE Publications 2020-06-17 2021-04 /pmc/articles/PMC7983338/ /pubmed/33736510 http://dx.doi.org/10.1177/0271678X20929430 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Articles Hoogeveen, Evelien S Pelzer, Nadine Ghariq, Eidrees van Osch, Matthias JP Dahan, Albert Terwindt, Gisela M Kruit, Mark C Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
title | Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
title_full | Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
title_fullStr | Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
title_full_unstemmed | Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
title_short | Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
title_sort | cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983338/ https://www.ncbi.nlm.nih.gov/pubmed/33736510 http://dx.doi.org/10.1177/0271678X20929430 |
work_keys_str_mv | AT hoogeveeneveliens cerebrovascularreactivityinretinalvasculopathywithcerebralleukoencephalopathyandsystemicmanifestations AT pelzernadine cerebrovascularreactivityinretinalvasculopathywithcerebralleukoencephalopathyandsystemicmanifestations AT ghariqeidrees cerebrovascularreactivityinretinalvasculopathywithcerebralleukoencephalopathyandsystemicmanifestations AT vanoschmatthiasjp cerebrovascularreactivityinretinalvasculopathywithcerebralleukoencephalopathyandsystemicmanifestations AT dahanalbert cerebrovascularreactivityinretinalvasculopathywithcerebralleukoencephalopathyandsystemicmanifestations AT terwindtgiselam cerebrovascularreactivityinretinalvasculopathywithcerebralleukoencephalopathyandsystemicmanifestations AT kruitmarkc cerebrovascularreactivityinretinalvasculopathywithcerebralleukoencephalopathyandsystemicmanifestations |